Drug Therapy

Contributing journals to this collection:
JAMA & Archives Journals

Citations 291-300 of 3664 total displayed.

Past content

Original Articles
National Patterns in Antidepressant Medication Treatment

Mark Olfson; Steven C. Marcus
Arch Gen Psychiatry 2009; 66: 848-856. [Abstract] [Full text] [PDF]  

The Cutting Edge
Response of Keratosis Lichenoides Chronica to Efalizumab Therapy

Carlos Muñoz-Santos; Mireia Yébenes; Jorge Romaní; Jesús Luelmo
Arch Dermatol 2009; 145: 867-869. [Extract] [Full text] [PDF]  

Studies
Antioxidant Supplementation and Risk of Incident Melanomas: Results of a Large Prospective Cohort Study

Maryam M. Asgari; Sonia S. Maruti; Lawrence H. Kushi; Emily White
Arch Dermatol 2009; 145: 879-882. [Abstract] [Full text] [PDF]  

Observations
Sarcoidal Anemia and Leukopenia Treated With Methotrexate and Mycophenolate Mofetil

Andrew H. Kalajian; Jonathan R. Van Meter; Jeffrey P. Callen
Arch Dermatol 2009; 145: 905-909. [Abstract] [Full text] [PDF]  

Letters to the Editor
Family-Focused Treatment for Adolescents With Bipolar Disorder

Christine Kuehner
Arch Gen Psychiatry 2009; 66: 915-a. [Extract] [Full text] [PDF]  

Letters to the Editor
Heart Rate Variability and Depression: Sleep-Related Breathing Disorders as Confounder?

Lara Kierlin; Frisca Yan-Go
Arch Gen Psychiatry 2009; 66: 915. [Extract] [Full text] [PDF]  

Observations
Interferon Beta–Induced Panniculitis Mimicking Acute Appendicitis

Frédéric Poulin; Philippe Rico; Jean Côté; Louis R. Bégin
Arch Dermatol 2009; 145: 916-917. [Abstract] [Full text] [PDF]  

Letters to the Editor
Family-Focused Treatment for Adolescents With Bipolar Disorder—Reply

David J. Miklowitz; David A. Axelson; Boris Birmaher; L. Miriam Dickinson
Arch Gen Psychiatry 2009; 66: 916. [Extract] [Full text] [PDF]  

Observations
Cutaneous Pigmentation After Photosensitivity Induced by Vandetanib Therapy

Heidi H. Kong; Howard A. Fine; Jere B. Stern; Maria L. Chanco Turner
Arch Dermatol 2009; 145: 923-925. [Abstract] [Full text] [PDF]  

Commentaries
Progressive Multifocal Leukoencephalopathy, Efalizumab, and Immunosuppression: A Cautionary Tale for Dermatologists

Benjamin D. Korman; Kenneth L. Tyler; Neil J. Korman
Arch Dermatol 2009; 145: 937-942. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367